205 related articles for article (PubMed ID: 24155248)
1. Premenopausal serum sex hormone levels in relation to breast cancer risk, overall and by hormone receptor status - results from the EPIC cohort.
Kaaks R; Tikk K; Sookthai D; Schock H; Johnson T; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Dossus L; Baglietto L; Rinaldi S; Chajes V; Romieu I; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Tumino R; Ricceri F; Mattiello A; Buckland G; Ramón Quirós J; Sánchez MJ; Amiano P; Chirlaque MD; Barricarte A; Bas Bueno-de-Mesquita H; van Gils CH; Peeters PH; Andersson A; Sund M; Weiderpass E; Khaw KT; Wareham N; Key TJ; Travis RC; Merritt MA; Gunter MJ; Riboli E; Lukanova A
Int J Cancer; 2014 Apr; 134(8):1947-57. PubMed ID: 24155248
[TBL] [Abstract][Full Text] [Related]
2. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
3. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
[TBL] [Abstract][Full Text] [Related]
4. Postmenopausal serum sex steroids and risk of hormone receptor-positive and -negative breast cancer: a nested case-control study.
James RE; Lukanova A; Dossus L; Becker S; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Mesrine S; Engel P; Clavel-Chapelon F; Chang-Claude J; Vrieling A; Boeing H; Schütze M; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Krogh V; Panico S; Tumino R; Sacerdote C; Rodríguez L; Buckland G; Sánchez MJ; Amiano P; Ardanaz E; Bueno-de-Mesquita B; Ros MM; van Gils CH; Peeters PH; Khaw KT; Wareham N; Key TJ; Allen NE; Romieu I; Siddiq A; Cox D; Riboli E; Kaaks R
Cancer Prev Res (Phila); 2011 Oct; 4(10):1626-35. PubMed ID: 21813404
[TBL] [Abstract][Full Text] [Related]
5. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA).
Sturgeon SR; Potischman N; Malone KE; Dorgan JF; Daling J; Schairer C; Brinton LA
Cancer Causes Control; 2004 Feb; 15(1):45-53. PubMed ID: 14970734
[TBL] [Abstract][Full Text] [Related]
7. Prediagnostic Circulating Levels of Sex Steroid Hormones and SHBG in Relation to Risk of Ductal Carcinoma
Arthur RS; Xue X; Rohan TE
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):1058-1066. PubMed ID: 32127398
[TBL] [Abstract][Full Text] [Related]
8. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort.
Sieri S; Krogh V; Bolelli G; Abagnato CA; Grioni S; Pala V; Evangelista A; Allemani C; Micheli A; Tagliabue G; Schunemann HJ; Menard S; Berrino F; Muti P
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):169-76. PubMed ID: 19124495
[TBL] [Abstract][Full Text] [Related]
9. Circulating prolactin and breast cancer risk among pre- and postmenopausal women in the EPIC cohort.
Tikk K; Sookthai D; Johnson T; Rinaldi S; Romieu I; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Pala V; Tumino R; Rosso S; Panico S; Agudo A; Menéndez V; Sánchez MJ; Amiano P; Huerta Castaño JM; Ardanaz E; Bueno-de-Mesquita HB; Monninkhof E; Onland-Moret C; Andersson A; Sund M; Weiderpass E; Khaw KT; Key TJ; Travis RC; Gunter MJ; Riboli E; Dossus L; Kaaks R
Ann Oncol; 2014 Jul; 25(7):1422-1428. PubMed ID: 24718887
[TBL] [Abstract][Full Text] [Related]
10. Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort.
Schernhammer ES; Sperati F; Razavi P; Agnoli C; Sieri S; Berrino F; Krogh V; Abbagnato C; Grioni S; Blandino G; Schunemann HJ; Muti P
Breast Cancer Res; 2013 Jun; 15(3):R46. PubMed ID: 23777922
[TBL] [Abstract][Full Text] [Related]
11. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Allen NE; Key TJ; Dossus L; Rinaldi S; Cust A; Lukanova A; Peeters PH; Onland-Moret NC; Lahmann PH; Berrino F; Panico S; Larrañaga N; Pera G; Tormo MJ; Sánchez MJ; Ramón Quirós J; Ardanaz E; Tjønneland A; Olsen A; Chang-Claude J; Linseisen J; Schulz M; Boeing H; Lundin E; Palli D; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Bingham S; Khaw KT; Bueno-de-Mesquita HB; Trichopoulou A; Trichopoulos D; Naska A; Tumino R; Riboli E; Kaaks R
Endocr Relat Cancer; 2008 Jun; 15(2):485-97. PubMed ID: 18509001
[TBL] [Abstract][Full Text] [Related]
12. Premenopausal serum androgens and breast cancer risk: a nested case-control study.
Zeleniuch-Jacquotte A; Afanasyeva Y; Kaaks R; Rinaldi S; Scarmo S; Liu M; Arslan AA; Toniolo P; Shore RE; Koenig KL
Breast Cancer Res; 2012 Feb; 14(1):R32. PubMed ID: 22339988
[TBL] [Abstract][Full Text] [Related]
13. Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk.
Dorgan JF; Stanczyk FZ; Kahle LL; Brinton LA
Breast Cancer Res; 2010; 12(6):R98. PubMed ID: 21087481
[TBL] [Abstract][Full Text] [Related]
14. Sex hormone measurements using mass spectrometry and sensitive extraction radioimmunoassay and risk of estrogen receptor negative and positive breast cancer: Case control study in UK Collaborative Cancer Trial of Ovarian Cancer Screening (UKCTOCS).
Fourkala EO; Blyuss O; Field H; Gunu R; Ryan A; Barth J; Jacobs I; Zaikin A; Dawnay A; Menon U
Steroids; 2016 Jun; 110():62-69. PubMed ID: 27091764
[TBL] [Abstract][Full Text] [Related]
15. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
16. Sex hormone levels and risk of breast cancer with estrogen plus progestin.
Farhat GN; Parimi N; Chlebowski RT; Manson JE; Anderson G; Huang AJ; Vittinghoff E; Lee JS; Lacroix AZ; Cauley JA; Jackson R; Grady D; Lane DS; Phillips L; Simon MS; Cummings SR
J Natl Cancer Inst; 2013 Oct; 105(19):1496-503. PubMed ID: 24041978
[TBL] [Abstract][Full Text] [Related]
17. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
18. Sex-steroid hormones and risk of postmenopausal estrogen receptor-positive breast cancer: a case-cohort analysis.
Albers FEM; Lou MWC; Dashti SG; Swain CTV; Rinaldi S; Viallon V; Karahalios A; Brown KA; Gunter MJ; Milne RL; English DR; Lynch BM
Cancer Causes Control; 2024 Jun; 35(6):921-933. PubMed ID: 38363402
[TBL] [Abstract][Full Text] [Related]
19. Added Value of Serum Hormone Measurements in Risk Prediction Models for Breast Cancer for Women Not Using Exogenous Hormones: Results from the EPIC Cohort.
Hüsing A; Fortner RT; Kühn T; Overvad K; Tjønneland A; Olsen A; Boutron-Ruault MC; Severi G; Fournier A; Boeing H; Trichopoulou A; Benetou V; Orfanos P; Masala G; Pala V; Tumino R; Fasanelli F; Panico S; Bueno de Mesquita HB; Peeters PH; van Gills CH; Quirós JR; Agudo A; Sánchez MJ; Chirlaque MD; Barricarte A; Amiano P; Khaw KT; Travis RC; Dossus L; Li K; Ferrari P; Merritt MA; Tzoulaki I; Riboli E; Kaaks R
Clin Cancer Res; 2017 Aug; 23(15):4181-4189. PubMed ID: 28246273
[No Abstract] [Full Text] [Related]
20. Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional study.
Secreto G; Meneghini E; Venturelli E; Cogliati P; Agresti R; Ferraris C; Gion M; Zancan M; Fabricio AS; Berrino F; Cavalleri A; Micheli A
Int J Biol Markers; 2011; 26(4):241-6. PubMed ID: 22180173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]